Clinical Trial

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Name: A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia — clinical trial record (NCT06821945)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-02-11.

Trial Details

NCT Number	NCT06821945
Lead Sponsor	Boryung Pharmaceutical Co., Ltd
Conditions	Schizophrenia
Enrollment	120 participants
Start Date	2025-05-30
Primary Completion	2027-05 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2025-09-15